Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07405086Phase 4Recruiting
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
PrincipalinvestigatorStart date: 2026-04-24

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmAdvanced Renal Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma+6 more
Similarity Score13%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Solid Neoplasm+6 more
Similarity Score13%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmMetastatic MelanomaMetastatic Renal Cell Carcinoma+2 more
Similarity Score7%

Sumanta K Pal

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Stage IV Renal Cell Cancer AJCC v8Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+2 more
Similarity Score7%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmStage III Lung Cancer AJCC v8+1 more
Similarity Score6%

Michael Schweizer

Fred Hutch/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Solid NeoplasmStage IV Lung Cancer AJCC v8
Similarity Score4%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
Similarity Score4%

David Hui, MD

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
Similarity Score3%

Douglas Adkins, M.D.

Washington University School of Medicine

Related
11 trials

Shared therapeutic areas:

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Similarity Score3%

George Blumenschein, MD

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07405086Phase 4PrincipalInvestigator

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
Recruiting

All 1 trials loaded